Is Sodium Hyaluronate Skin Hydration Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Sodium Hyaluronate Skin Hydration Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Skin hydration/elasticity improved sustainably for 3 months, with only 1.67% adverse events and no serious ones. [Yang Rongya (2026); evidence level 2] - This large-scale randomized controlled trial complements the existing evidence base for the novel sodium hyaluronate composite, strongly supporting its safty and clinical efficacy in facial rejuvenation through mesotherapy. [Yang Rongya (2026); evidence level 2] - The GAIS score distribution demonstrated that within the treatment group, 5.57% of subjects were rated as “very much improved,” 41.11% as “much improved,” and 50.87% as “improved.” In contrast, only 6 subjects (3.95%) in the control group showed improvement of any degree, whereas the remainder were rated as “no change” or “worse” (Table). [Yang Rongya (2026); evidence level 2] - Is this novel sodium hyaluronate composite containing 4 amino acids safe and effective for facial rejuvenation when administered via mesotherapy? [Yang Rongya (2026); evidence level 2] - Objective This study aimed to determine whether liposomal delivery enhances the effects of a collagen tripeptide-containing formulation on dermal structural and biomechanical parameters, as well as appearance-related skin properties, compared with a nonliposomal formulation and placebo. [Lin YK (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.